12
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LITERATURE ALERTS

Pages 665-679 | Published online: 29 Sep 2008

References

  • A comparative analysis of lipid-cornplexed and liposomal am photericin B preparations in hematological oncology. CLARK, A. D., MCKENDRICK, S., T ANSEY, P. J., FRANKLIN, I. M., and CHCPRA, R., British Journal of Haematology, 1998, 103 (1), 198–204.
  • A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses. CHILDERS, N. K., TONG, G., MITCHELL, S., KIRK, K., RUSSELL, M. W., and MICHALEK, S. M., Infection And Immunity, 1999, 67 (2), 618–623.
  • A liposomal hydrogel for the prevention of bacterial adhesion to catheters. DITIZIQ V., FERGUSCN, G. W., MITTELMAN, M. W., KHOURY, A. E., BRUCE, A. W., and DICOSMQ F., Biomaterials, 1998, 19 (20), 1877–1884.
  • A liposomal model that mimics the cutaneous production of vitamin D3. Studies of the mechanism of the membrane-enhanced thermal isomerization of previtamin D3 to vitamin D3. TIAN, X. Q., and HCLICK, M. F., Journal of Biological Chemistry, 1999, 274 (7), 4174–4179.
  • A model for oxygen transport in microencapsulated islets. IWATA, H., PARK, Y. G., and IKADA, Y., Materials Research Society Symposium Proceedings, 1998, 530 (Biomaterials Regulating Cell Function and Tissue Development), 19–24.
  • A new preparation method for protein loaded poly(DL-lactic-co-glycolic acid) microspheres and protein release mechanism study. PARK, T. G., YONG, L. H., and SUNG, N. Y., Journal of Controlled Release, 1998, 55 (2, 3), 181–191.
  • A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. LAVERMAN, P., DAMS E. T °YEN, W. J., STORK G., KCENDERS, E. B., PREVOST, R., VAN DER MEER, J. W., CORSTENS, F. H., and Bonus/AN O. C., Journal of Nuclear Medicine, 1999, 40 (1), 192–197.
  • A phase II study of Doxil (liposom al doxorubicin): lack of activity in poor prognosis soft tissue sarcomas. GARCIA, A. A., KEMPF, R. A., ROGERS, M., and MuGGIA F. M., Annals of Oncology, 1998, 9(10), 1131–1133.
  • A poly(DL-lactide-co-glycolide) microsphere depot system for delivery of haloperidol. CHENG, Y. H., ILLUM L., and DAVIS, S. S., Journal of Controlled Release, 1998, 55 (2, 3), 203–212.
  • A simple in vitro model to study the release kinetics of liposome encapsulated material. PEscHKA, R., DENNERY, C., and SZCKA, F. C. JR, Journal of Controlled Release, 1998, 56 (1-3), 41–51.
  • A spectrophotometric method for the determination of hydroperoxides in liposomes. CIMATQ A., FAcoRRQ G., AGUIRRE, F., HAGER, A., DE PAOLI, T., IHLQ J., FARACH, H. A., and POOLE. C. P. JR., Spectrochimica Acta, Part A, 1998, 54A (12), 2001–2008, ISSN: 0584–8539.
  • Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. WIISSIG, V., WHITEMAN, K. R., and TCRCHIL1N V. P., Pharmaceutical Research, 1998, 15 (10), 1552–1556.
  • Acute administration of liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury. NIIBCRI, K., YCKOYAMA, H., CRESTA NELLQ J. A., and WHITMAN, G. J. R., Journal of Surgical Research, 1998, 79 (2), 141–145.
  • Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. KURZNIAN, I. D., MACEWEN E. G., RC8ENDIAL, R. C., Fox, L. E., KELLER, E. T., HELFAND, S. C., VAIL, D. M., DumanG, R. R., MADEWELL, B. R., RODRIGUEZ C. O. JR, et al., Clinical Cancer Research, 1995, 1 (12), 1595–1601.
  • Advantages of microencapsulation as an immunoprotection method in the transplantation of pancreatic islets. SUN, A. M., Annals Of Transplantation, 1997, 2 (3), 55–62. 66 Refs.
  • Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: canine studies. KHANNA, C., HASZ, D. E., KLAUSNER, J. S., and ANDERSON, P. M., Clinical Cancer Research, 1996, 2 (4), 721–734.
  • Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form. PARTHASARATHY, R., and MEHEA, K., Cancer Letters, 1998, 134 (2), 121–128.
  • Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome). FIELDING, R. M., LEWIS, R. O., and MOON MCDERMOTT, L., Pharmaceutical Research, 1998, 15(11), 1775–1781.
  • Amine composition influences apparent activity of enzyme in charged film microcapsules. PATIL, R. T., and SPEAKER, T. J., Journal of Microencapsulation, 1998, 15 (6), 739–745.
  • An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposom al am photericin B for treatment of invasive aspergillosis. ELLIS, M., SPENCE, D., DE PAUW, B., MEUNIER, F., MARINUS, A., COLLETTE, L., SYLVESTER, R., MESS, J., BOOTTAERTS, M., SELLESLAG, D., KRCMERY, V., VON SINNER, W., MACDONALD, P., DOYEN, C., and VANDERCAM B., Clinical Infectious Diseases, 1998, 27 (6), 1406–1412.
  • An original method for studying in vitro the enzymic degradation of crosslinked starch microspheres. HAMDI, G., PONCHEL, G., and DUCHENE, D., Journal of Controlled Release, 1998, 55(2, 3), 193–201.
  • Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines. EYLES, J. E., SPIERS, I. D., WILLIAMSON, E. D., and ALPAR, H. O., Vaccine, 1998, 16 (20), 2000–2009.
  • Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposomes. WATARAL S., HAN, M., and KODAMA, H., Journal of Veterinary Medicine Science, 1998, 60 (9), 1047–1050.
  • Antileukemia effects of anti-CD3/interleukin-2 co-stimulated killer cells and interleukin-2 liposomes plus kappa-selenocarrageenan. WEI, H., JIA, Z., ZHAQ H., and MA, L., Zhonghua Weishengwuxue He Mianyixue Zazhi, 1998, 18 (5), 410–413.
  • Antimicrobial activity of Am Bisome and non-liposom al am photericin B following uptake of Candida glabrata by murine epidermal Langerhans cells. SPERRY, P. J., CUA, D. J., WETZEL, S. A., and ADLER M OGRE, J. P., Medical Mycology, 1998, 36 (3), 135–141.
  • Antitumor activity of RES-avoiding liposomal 5'-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-.beta.-D-arabino-pentofuranosylcytosine (DPP-CNDAC). ASAL T., 01W, N., KUROHANF, K., YUYAMA, Y., OKADA, S., SHUT() S., AWANQ H., and MATSUDA, A., Drug Delivery Systems, 1998, 13 (5), 341–346.
  • Antitumor characteristics of irinotecan-containing microspheres of poly(nr-lactic acid) or poly(nr-lactic acid-co-glycolic acid) copolymers. MACHIDA, Y., ONISM, H., MORIKAWA, A., and MACHIDA, Y., ST P Pharma Sciences, 1998, 8 (3), 175–181.
  • Antitumor effect of cisplatin encapsulated in therm osensitive liposomes combined with regional hyperthermia. KIHARA, T., Tokyo Joshi Ika Daigaku Zasshi, 1998, 68 (11/12), 852–860.
  • Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells. T ANA, W ATARAL S., ONUMA, M., AIDA, Y., KAKIDANI, H., KODAMA, H., and YASUDA, T., Japanese Journal of Cancer Research, 1998, 89 (11), 1202–1211.
  • Apoptosis of human neuroblastoma cells induced by liposome-encapsulated Fenretinide. PAGNAN, G., CARIDI, G., MONTALDQ P. G., BADQ M., CHIESA V., ALLEN T. M., and PONZONI, M., Journal of Liposome Research, 1998, 8 (3), 401–423.
  • Applications of liposome technology to overcome multidrug resistance in solid tumors. KRISHNA R., and MAYER, L. D., NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 95–107.
  • Approaches for gene therapy by protein-modified liposomes. KANEDA, Y Iderzshi Igaku, 1998, 2 (2), 275–281.
  • Artificial colloid tracer tests: development of a compact online microsphere counter and application to soil column experiments. NIEHREN, S., and KINZELBACH, W., Journal of Contamination Hydrology, 1998, 35 (1-3), 249–259.
  • Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. KAWAKAML S., YAMASHITA, F., NISHIKAWA, M., T AKAKURA, Y., and HASHIDA, M., Biochemical and Biophysical Research Communications, 1998, 252 (1), 78–83.
  • Basic fibroblast growth factor impregnated hydrogel microspheres for embolization of cerebral arteriovenous malformations. NISHI, S., NAKAYAMA, Y., HASHIMOTO N., and MATSUDA, T., ASAIO Journal, 1998, 44 (5), M405–M410.
  • Binding of adriamycin to liposomes as a probe for membrane lateral organization. SODERLUND, T., JUTILA A., and KINNUNEK P. K., Biophysical Journal, 1999, 76(2), 896–907.
  • Binding of avidin modified antibody to biotinylated metal supported membranes and liposomes changes the physical properties of lipid bilayer. HIANIK, T SNETDARKOVA, M., RDIAK, M., KRIVANEK, R., MFSZAR, E., DUTSIK, J., STEPANEK, I., and NIRDLEus, D. P., Genetics of Physiological Biophysics, 1998, 17 (3), 239–252.
  • Biocompatibility of alginate analyzed using liposome as a biomembrane model. GONG, Y., CHEN, X., ZENG, X., ZHANG, X., and ZHAO N., Tsinghua Science Technology, 1997, 2 (1), 478–481.
  • Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection. SONE, P. N., BROWN, D., SAFFIF, R., SAVAGE, K., MOORE, D., GREGORIADIS, G., and DUSHEEKO G. M., Hepatology (Philadelphia), 1998, 28 (5), 1402–1410, ISSN: 0270–9139.
  • Biologically active ligand-bearing polymer-grafted liposomes. ZALIPSKY, S., GITTELmAN, J., MULLAH N., QAZEN, M. M., and HARDING, J. A., NATO AS I Series, Series A, 1998, 300 (Targeting of Drugs 6), 131–138.
  • Capacitance-voltage property of composite microsphere monolayer with polymer/Fe203/ polymer structure. QIAN, X. M., DU, H., ZHANG, X. T LI, L. S., WANG, D. Y., TANG, J., LU, R., BAT, Y. B., LI, T. J., TANG, X. Y., LI, W. M., and HU, D. B., Supramolecular Science, 1998,5 (5-6), 683–686.
  • Cationic liposome-mediated efficient induction of type I interferons by a low dose of poly I:poly C in mouse cell lines. OKAMOTO S., WATANABE, Y., T AKAKURA, Y., and HAsHIDA, M., Journal of Biochemistry (Tokyo), 1998, 124 (4), 697–701.
  • Cationic liposome-mediated gene transfer during acute pancreatitis: tissue specificity, duration, and effects of acute inflammation. DENHAlvt W., YANG, J., MACKAY, S., T ANNAH ELL, C., CARTER, G., A BOUHAMIT, A., M OLDAWER, L. L., and NCRMAN, J., Journal of Gastrointestinal Surgery, 1998, 2 (1), 95–101.
  • Cellular response in subretinal neovascularization induced by bFGF-impregnated micro-spheres. KIMURA, H., S PEE, C., SAKAMOTO T HINTON, D. R., OGURA, Y., T ABATA, Y., IKADA, Y., and RYAN, S. J., Investigative Ophthalmology And Visual Science, 1999, 40 (2), 524–528.
  • Cerebral aspergillosis: long term efficacy and safety of liposom al am photericin Bin kidney transplant. CARLINI, A., ANGELINI, D., BURROWS, L., DE QUIRIOD G., and ANTONELLI, A., Nephrology, Dialysis, Transplantation, 1998, 13 (10), 2659–2661.
  • Characterization and transplantation of agarose microencapsulated canine islets of Langer-hans. T ASHIRO H., IWATA, H., WARNCCK, G. L., T AKAGI, T., M ACHIDA, H., IKADA, Y., and T SUR, T., Annals Of Transplantation, 1997, 2 (3), 33–39.
  • Characterization of liposomes and their effect on the properties of Cheddar cheese during ripening. LALOY, E., VUILLEMARD, J. C., and SIMARD, R., Lait, 1998, 78 (4), 401–412.
  • Chem o-em bolization of experimental liver metastases. Part 1. Distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy. BASTIAN, P., BARTKOWSKI, R., KCEHLER, H., and KISSEL, T., European Journal of Pharmacy and Biopharmacy, 1998, 46 (3), 243–254.
  • Chitosan microspheres: modification of polymeric chem-physical properties of spray-dried microspheres to control the release of antibiotic drug. MI, F. L., WONG, T. B., SHYu, S. S., and CHANG, S. F., Journal of Applied Polymer Science, 1999, 71 (5), 747–759.
  • Chitosan/polyethylene glycol-alginate microcapsules for oral delivery of hirudin. CHANDY, T., MOORADIAN, D. L., and RAQ G. H. R., Journal of Applied Polymer Science, 1998, 70(11), 2143–2153.
  • Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome. DAVIS, S. C., and SZOKA, F. C. JR., Bioconjugate Chemistry, 1998, 9 (6), 783–792.
  • Classification and properties of 64 multiplexed microsphere sets. KETTMAN, J. R., DAviEs, T CHANDLER, D., OLIVER, K. G., and FULTCN1, R. J., Cytometry, 1998, 33 (2), 234–243.
  • Clearance of liposome-incorporated ciprofloxacin after intravitreal injection in rabbit eyes. WIECHENS, B., KRAUSSE, R., GRAMMER, J. B., NEUMANN, D., PLEYER, U., and DUNCKER, G. I., Klinische Monatsblatter Fur Augenheilkunde, 1998, 213 (5), 284–292.
  • Cloning and characterization of a 150 kDa microsphere antigen of Theileria parva that is immunologically cross-reactive with the polymorphic immunodominant molecule (PIM). SKILTEN, R. A., BISHOP, R. P., WELLS, C. W., SPOONER, P. R., GOBRIGHT, E., NKONGF, C., MUSCKE A. J., MACKLIN, M., and IAMS, K. P., Parasitology, 1998, 117 (4), 321–330.
  • CMS used for microencapsulation material. ZHANG, Y., and LIU, Q., Ship in Gongy e Keji, 1998, (1), 18–19. 17.
  • Coagulation and phenyl stacks on the surfaces of polystyrene microspheres. XU, W., and HUA, Z. Y Gaoderzg Xuexiao Huaxue X uebao, 1998, 19(10), 1684–1688, ISSN: 0251–0790.
  • Color characteristics of microencapsulated pigments. PASHUHENKO V. L., KuDYuKov, Y. P., PASHCHENKO E. G., and MCRO4 V. A., Lakokras Mater Ikh Primen, 1998, (8), 26–27.
  • Comparative efficacy of liposom al FK506 with FK506. MOFFATT, S. D., McALisTER, V., CALNE R. Y., and METCALFE, S., Transplantation Proceedings, 1998, 30 (8), 4066–4067.
  • Comparative pharm acokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. NEWMAN, M. S., COLBERN G. T., WORKING, P. K., ENGBERS, C., and AMANITA, M. A., Cancer Chemotherapy And Pharmacology, 1999, 43 (1), 1–7.
  • Comparative study of 'in vitro' release of anti-inflammatory drugs from polylactide-co-glycolide microspheres. CASTELLI, F., CONTI, B., MACCARRONE D. E., CONTE, U., and PUGLISI, G., International Journal of Pharmacy, 1998, 176 (1), 85–98.
  • Comparative testing between conventional and microencapsulation approaches in control-ling pyrite oxidation. VANDIVIERE M. M., and EVANGELOU, V. P., Journal of Geochemistry Explorations, 1998, 64 (1-3), 161–176.
  • Comparison between aqueous and non-aqueous solvent evaporation methods for microen-capsulation of drug-resin complexes. TORRES, D., BOWQ L., BLANCO D., and VILA, J. J. L., International Journal of Pharmacy, 1998, 173 (1, 2), 171–182.
  • Complement dependent and independent liposome uptake by peritoneal macrophages: cholesterol content dependency. HUGNG, T. M., HARASHIMA, H., and KIWADA, H., Biological And Pharmaceutical Bulletin, 1998, 21 (9), 969–973.
  • Conjugation of drug to poly(D, L-lactic-co-glycolic acid) for controlled release from biode-gradable microspheres. OH, J. E., NAM Y. S., LEE, K. H., and PARK, T. G., Journal of Controlled Release, 1999, 57 (3), 269–280.
  • Continuous separation of serum proteins using a stirred cell charged with carboxylated and sulfonated microspheres. LEE, J. H., YOON, J. Y., and KIM W. S., Biomedical Chromato-graphy, 1998, 12 (6), 330–334.
  • Degradation of double-walled polymer microspheres of PLLA and P (CPSA)20:80. I. In vitro degradation. LEACH, K. J., and MATIROWITZ E., Biomaterials, 1998, 19 (21), 1973–1980.
  • Degradation of double-walled polymer microspheres of PLLA and P (CPSA)20:80. II. In vivo degradation. LEACH, K. J., T AKAHASHI, S., and MATHIOWIT4 E., Biomaterials, 1998, 19 (21), 1981–1988.
  • Design and synthesis of novel am phiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. SuEDREGT, L. A., RENSEN, P. C., RUMP, E. T., VAN S ANTBRINK, P. J., BUSTERBOSCH, M. K., VALENTBN, A. R., VANDER MAREL, G. A., VAN BOOM J. H., VAN BERKEL, T. J., and BIESSEN, E. A., Journal of Medicinal Chemistry, 1999, 42 (4), 609–618.
  • Determination of the internal morphology of poly (D, L-lactide) microspheres using stereo-logical methods. EHTEZAn, T., WASHINGTON, C., and MELIA, C. D., Journal of Controlled Release, 1999, 57 (3), 301–314.
  • Development and characterization of buoyant theophylline microspheres with near zero order release kinetics. STITHIT, S., CHEN, W., and PRICE, J. C., Journal of Microencapsulation, 1998, 15 (6), 725–737.
  • Development of a routine analysis method for liposome encapsulated recombinant inter-leukin-2. K OPPENHAGEN, F. J., STaus4 G., and UNDERBERG, W. J., Journal of Chromatography. B, Biomedical Sciences And Applications, 1998, 716 (1-2), 285–291.
  • Development of a signal measurement technique for application in multi-analyte liposome immunomigration assays. MATHAI, M., SIEBERT, K. J., SIEBERT, S. T. A., DURST, R. A., and REEVES, S. G., Food Agriculture Immunology, 1998, 10 (3), 195–202.
  • Development of ganciclovir microspheres from poly(DL-lactic-co-glycolide) acid for the treatment of AIDS-related cytomegalovirus retinitis. HERRERO V. R., BARCIA, E., NEGRO S., and REFOTO M. F., ST P Pharma Sciences, 1998, 8 (4), 237–240.
  • Diagnostic and therapeutic targeting of infectious and inflammatory diseases using sterically stabilized liposomes. STORM G., BAKKER, W. I. A. J. M., SCHEFFELERS, R. M., OVEN, W. J. G., CROMMELIN, D. J. A., CCRSTENS, F. H. M., and BCERMAN, O. C., NATO AS I Series, Series A, 1998, 300 (Targeting of Drugs 6), 121–130.
  • Different molecular weight chitosan microspheres: influence on drug loading and drug release. GENTA, I., PERUGINI, P., and PAVANETTQ F., Drug Development And Industrial Pharmacy, 1998, 24 (8), 779–784.
  • Differential scanning calorimetry: a tool to assess physical and chemical alterations in liposomes. SAMUNI, A. M., CROMMELIN, D. J. A., ZUDAM, N. J., and BARENHOLZ Y., Journal of Thermal Analysis Calorimetry, 1998, 51 (1), 37–48.
  • Diode laser-induced retinal thermal damage control with a liposome-dye system. DESMETTRE, T., DEVOISSELLF, J. M., SCULIE B. S., and MCRDCN, S., Journal Francais D Ophtalmologie, 1998, 21 (10), 714–722.
  • Diplasmenylcholine-folate liposomes: An efficient vehicle for intracellular drug delivery. RU, Y., WANG, S., LOW, P. S., and THOMPSON, D. H., Journal of the American Chemical Society, 1998, 120 (44), 11213–11218.
  • Direct video-microscopic observation of the dynamic effects of medical ultrasound on ultrasound contrast microspheres. KLIBANOV, A. L., FERRARA, K. W., HUGHES, M. S., WIBLE, J. H. JR., WOJDYLA, J. K., DAYTON, P. A., MORGAN, K. E., and BRANDENBURGER, G. H., Investigative Radiology, 1998, 33 (12), 863–870.
  • Discussion on releasing model and mechanism of microencapsulation. LI, G., YCNG, G., and XIAQ L., Shipin Gongye Keji, 1998, (2), 7–8.
  • Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposom al doxorubicin in the dog. KIYOKAWA, H., I GAWA, Y., MURAISHI, O., KATSUYAMA, Y., IIZUKA, K., and NISHIZAWA, O., Journal of Urology, 1999, 161 (2), 665–667.
  • Distribution of liposom al amikacin in various tissues of mice. GU, J., WANG, L., and ZHANG, J., Zhongguo Kangshengsu Zazhi, 1998, 23 (4), 294–297.
  • DNA transfection of insect cells efficiently mediated by stearylamine liposome. ZHANG, C., and WU, X., Shengwu Gongcheng Xuebao, 1998, 14 (1), 106–108.
  • Does the amount of an antitumor agent entrapped in liposomes influence its tissue distri-bution and cell uptake? Sadzuka, Y.HIROTA, S., Cancer Letters (Shannon, Ireland), 1998, 131 (2), 163–170. ISSN: 0304–3835.
  • Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. LI, X., HIRSH, D. J., CABRAL, L. D., ZIRKFL, A., GRUNER, S. M., JANOFF, A. S., and PERKINS, W. R., Biochimica et Biophysica Acta, 1998, 1415 (1), 23–40.
  • Effect of adrenalectomy on the slimming activity of liposome-carried oleoyl-estrone in the rat. GRASA, M. M., CABOT, C., ADAN, C., VILA, R., ESTEVF, M., ESTRUCH, J., FERNANDEZ L. A., REMESAR, X., and ALEMANY, M., International Journal of Obesity And Related Metabolic Disorders, 1998, 22 (12), 1225–1230.
  • Effect of different types of electrolyte on surface potential of liposom e of phosphatidylcholine (PC) and PC-cholesterol. TONG, H., and YAQ S., Wuli Huaxue Xuebao, 1998, 14 (11), 1043–1047.
  • Effect of doping small aromatic molecules on the physical properties and liposom al structure of lecithin. MINOBE, M., SAKURAI, I., SHIBATA, T., and KAWAMURA, Y., Molecular Crystals and Liquid Crystals Science Technology, Section A, 1998, 319, 75–87. ISSN: 1058-725X.
  • Effect of gastrointestinal protein adsorption on the in vitro release of AZT from ethyl cellulose microspheres. ABU, I. K. A., and LU, D. R., Pharmaceutical Developments and Technology, 1998, 3 (4), 495–501.
  • Effect of liposome-encapsulated hemoglobin, neo red cells, on hemorrhagic shock. USUBA, A., OSUKA, F., KIMURA, T., SATO R., OGATA, Y., GOTOH, H., KIMURA, T., and FUKUI, H., Surgery Today, 1998, 28 (10), 1027–1035.
  • Effect of polytyrosine on the hydrophobicity of hydroxyethyl starch microspheres. CHADHA, H., and DELUCA, P. P., Pharmaceutical Developments and Technology, 1998, 3 (4), 597–606.
  • Effect of sterols on melittin incorporation into liposom al membranes. ADAMYAN, S. Y., KAULIN, Y. A., KUZNETSCATA, I. M., TUROVEROV, K. K., and SHCHAGINA, L. V., T sitologiya, 1998, 40(8/9), 801–805.
  • Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-(35S)thio-triphosphate binding to liposomes with varying muscarinic receptor/Go protein stoi-chiometry. JAKUBIK, J., HAGA, T., and TUCEK, S., Molecular Pharmacology, 1998, 54(5), 899–906.
  • Effects of inhaled gases on the ultrasound contrast produced by microspheres containing air or perfluoropropane in anesthetized dogs. WIBLF, J. JR, WOIDYLA, J., BUGAT, J., and BRANDENBURGER, G., Investigative Radiology, 1998, 33 (12), 871–879.
  • Effects of liposome-encapsulated hemoglobin on phorbol ester-induced superoxide produc-tion and expression of costimulatory molecules by monocytes in vitro. FUTIHARA, M., IICEBUCHI, K., YAMAGUCHI, M., ABF, H., NIWA, K., and SEKIGUCHT, S., Artificial Cells, Blood Substitutes, And Immobilization Biotechnology, 1998, 26 (5-6), 487–495.
  • Efficient excitation energy transfer among multiple dyes in polystyrene microspheres. ROBERTS, D. V., WITTMERSHAUS, B. P., ZHANG, Y. Z., SWAN, S., and KLINCSICY, M. P., Journal of Luminescence, 1998, 79 (4), 225–231.
  • Electrophoretic behavior of stearylamine-containing liposomes. CASALS, E., SOLER, M., GALLARDQ M., and ESTELRICIT, J., Langmuir, 1998, 14 (26), 7522–7526.
  • Encapsulation of plasmid DNA in biodegradable poly(D,r-lactic-co-glycolic acid) micro-spheres as a novel approach for immunogene delivery. WANG, D., ROBINSON, D. R., KWON, G. S., and SAMUEL, J., Journal of Controlled Release, 1999, 57 (1), 9–18.
  • Encapsulation of various recombinant mammalian cell types in different alginate micro-capsules. PETRONE, M., Ross, C. J. D., HCRTELANQ G., BRASH, J. L., and CHANG, P. L., Journal of Biomedical Materials Research, 1998, 42 (4), 587–596.
  • Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing. FIEF, K., BOWER, M., COOPER, R. G., STEWART, L., ETHERIDGE, C. J., COOMBES, R. C., BULUWELA, L., and MILLER, A. D., Gene Therapy, 1998, 5 (5), 614–620.
  • Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. PULFER, S. K., and GALLO J. M., Journal of Drug Targeting, 1998, 6 (3), 215–227.
  • Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives. MCRIBF, K., T ANAKA, E., M ARUYAMA, K., and IWATSURU, M., Pharmaceutical Research, 1998, 15 (11), 1737–1742.
  • Enhanced fluorescence from two dye-doped microspheres due to dipole-dipole interaction. SONG, J. S., KIM, S. C., KWON, N., NNA, H., and JUL, W., Korean Physical Society, 1998, 33(3), 270–272.
  • Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. IGARTUA, M., HERNANDEZ R. M ESQUISABEL, A., GASCON, A. R., CALVO M. B., and PEDRAZ, J. L., Journal of Controlled Release, 1998, 56 (1-3), 63–73.
  • Enhancement of firefly bioluminescence using liposomes containing cationic components. KAARDATE, T., FunTA, T., TAM, AM, H., and WATANABF, H., Analytical Science, 1998, 14(6), 1115–1119.
  • Enhancement of liposomal gene delivery in human breast cancer cells by dimethyl sulf-oxide. JAIN, P. T., and GEWIRTZ D. A., International Journal of Molecular Medicine, 1998, 1 (3), 609–611.
  • Enzymatic reactions in liposomes using the detergent-induced liposome loading method. OBERHCLZER, T., MEYER, E., AMATO I., L USTIG, A., and M CNNARD, P. A., Biochimica et Biophysica Acta, 1999, 1416 (1-2), 57–68.
  • Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. MCRLOCK, M., KISSEL, T., Y. X., KOLL, H., and WINTER, G., Journal of Controlled Release, 1998, 56 (1-3), 105-115. Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres. SCHLENKF P., FRoHN, C., KLLTER, H., S ABALLUS, M., HAMMERS, H. J., ZAJAC, S R., and KIRCHNER, H., Cytometry, 1998, 33 (3), 310–317.
  • Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatographic assay. BAIN, D. F., MuNDAY, D. L., and COX, P. J., European Journal of Pharmaceutical Sciences, 1998, 7 (1), 57–65.
  • Evaluation of cerebral perfusion from bypass arteries using selective intraarterial micro-sphere tracer after vascular reconstructive surgery. NCCHIDE, I., OHTA S., UEDA, T., S HIRAISHI, M., W ATANABF, H., SAKAKI, S., and IKFZOF, J., American Journal of Neuroradiology, 1998, 19 (9), 1669–1676.
  • Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal admin-istration to rats. L UFTENSTEINER, C. P., S CHWENDENWEIN, I., PAUL, B., EICHLER, H. G., and VIERNSTEIN, H., Journal of Controlled Release, 1999, 57 (1), 35–44.
  • Experimental and numerical studies on the normal impact of microspheres with surfaces. Li, X., DUNN, P. F., and BRACH, R. M., Journal of Aerosol Science, 30 (4), 439–449.
  • Experimental observation on germicidal effect and stability of compound disinfectant containing microencapsulated sodium dichloroisocyanurate. KONG, F., ZHU, S., YAQ Y., and DUAN, W Zhongguo Xiaoduxue Zazhi, 1998, 15 (3), 160–162.
  • Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. LEVI, M., FRIEDERICH, P. W., M IDDLETCN, S., DE GROOT, P. G., Wu, Y. P., HARRIS, R., BIEMOND, B. J., H EHNEN, H. F., L EVIN, J., and TEN CATE, J. W., Nature Medicine, 1999, 5 (1), 107–111.
  • Flameless atomic absorption spectrometric determination of cisplatin content in cisplatin bletilla striata microspheres for targeting drug delivery. LI, W., CHEN, H., FFNG, G., and ZHENG, C., Guangpu Shiyanshi, 1998, 15 (5), 65–67.
  • Flow cytometric characterization and classification of multiple dual-color fluorescent microspheres using fluorescence lifetime. KELL J. F., and STEINKAMP, J. A., Cytometry, 1998, 33 (3), 318–323.
  • Fluorometric phospholipase assays based on polymerized liposome substrates. CHQ W., WU, S. K., Y 00N, E., and L ICHTFNBERGOVA, L., Methods In Molecular Biology, 1999, 109, 7–17. 14 Refs.
  • Function and fate of agarose microcapsules containing allogeneic islets in rat recipients. HASEGAWA, Y., NAKAGAWARA, G., IMAMURA, Y., IWATA, H., and I KADA, Y., Polymer Advances in Technology, 1998, 9 (10-11), 794–798.
  • Gamma irradiation effects on poly(m-lactide-co-glycolide) microspheres. MONTANARI, L., COSTANTINI, M., S IGNORETTI, E. C., VALVO L., S ANTUCCI, M., BARTOLOMEL M., FATTIBENE, P., °NMI, S., FAUCITANO A., CCNTI, B., and GENTA, I., Journal of Controlled Release, 1998, 56(1-3), 219–229.
  • Gelatin as microencapsulating agent for beta-carotene. ZHU, X., XU, S., and WANG, Z., Shipin Yu Fajiao Gongye, 1998, 24 (2), 11–15.
  • Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint. BROWN, K. E., L EONG, K., HUANG, C. H., DALAL, R GREEN, G. D., H AIMES, H. B., JIMENEZ P. A., and BATHON, J., Arthritis And Rheumatism, 1998, 41 (12), 2185–2195.
  • Grafted polymeric microspheres: a synthetic approach to structurally well-defined brush polymers. JAYACHANDRAN, K. N., and CHATTERJI, P. R., Journal of Macromolecular Science, Pure Applied Chemistry, 1998, A35 (12), 1971–1986, ISSN: 1060–1325.
  • Granulocyte-macrophage colony-stimulating factor protects dendritic cells from liposome-encapsulated dichloromethylene diphosphonate-induced apoptosis through a Bc1-2-mediated pathway. RABINOVICH, G. A., RIFRA, C. M., and IRIBARREN, P., European Journal of Immunology, 1999, 29 (2), 563–570.
  • Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor. NISHITA, T., Osaka City Medical Journal, 1998, 44(1), 73–83.
  • Hemolytic activity of a dental adhesive monomer and its interaction with dipalmitoyl phosphatidylcholine liposomes; NMR and DSC measurements. FUJISAWA, S., and KADOMA, Y., Journal of Thermal Analytical Calorimetry, 1998, 51 (1), 151–160.
  • High-Q whispering gallery modes from a composite system of GaAs quantum well and fused silica microsphere. FAN, X., DCRAN, A., and WANG, H., Applied Physics Letters, 1998, 73(22), 3190–3192.
  • Histological methods to determine blood flow distribution with fluorescent microspheres. LUCHTEL, D. L., BOYKIN, J. C., BERNARD, S. L., and GLENNY, R. W., Biotechnic and Histo-chemistry, 1998, 73 (6), 291–309. 26 Refs.
  • Identification of the in vivo topically applied 'human-identical' ceramides included in negatively charged liposomes. RODRIGUES, L., DA SILVA, P. A., PINTO P., GALEGQ N., SILVA, N., and PEREIRA, L. M., Bollettino Chimico Farmaceutico, 1998, 137 (10), 395–402.
  • Immunization with recombinant class 1 outer-membrane protein from Neisseria meningi-tidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against. CHRISTODOULIDES, M., BROOKS, J. L., RATTUF, E., and HECKELS, J. E., Microbiology (Reading, UK), 144 (11), 3027-3037.
  • Impact of liposomes as delivery systems in veterinary medicine. SALLOVITZ, J. M., MENGBINI, M. I. Z., and LANUSSF, C. E., Veterinary Research, 1998, 29 (5), 409–430.
  • Im provement of heat stability of flam e retardant SBC by microencapsulation. LU, J., JIANG, G., and YACt J., Suliao Gongye, 1998, 26 (3), 125–127.
  • In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination. GIUNCHEDI, P., CCNTI, B., SCALIA, S., and CCNTE, U., Journal of Controlled Release, 1998, 56 (1-3), 53–62.
  • In vivo characteristics of injectable poly(Dt-lactic acid) microspheres for long-acting drug delivery. KOBAYASHI, D., T SUBUKU, S., YAMANAKA, H., ASANQ M., MIYAJIMA, M., and VCSHIDA, M., Drug Development And Industrial Pharmacy, 1998, 24 (9), 819–825.
  • In vivo evaluation of arteether liposomes. BAYastit M. A., AL ANGARY, A. A., AL MFSHAL, M. A., and AL DARDIRI, M. M., International Journal of Pharmacy, 1998, 175 (1), 1–7.
  • Induction and maintenance of monocyte cytotoxicity during treatment with liposomes containing muramyl tripeptide despite tachyphylaxis to the cytokine response. GALLIGIONI E., FAVARQ D., S ANrAROSA, M QUAIA, M., S PALM, A., FRESCHI, A., and A LBFRTI, D., Clinical Cancer Research, 1995, 1 (5), 493–499.
  • Induction of anti-idiotypic hum oral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biode-gradable microspheres. MA, J., SAMUEL, J., KWCN, G. S., NCUJAIM A. A., and MADIYALAKAN, R., Cancer Immunology and Immunotherapy, 1998, 47 (1), 13–20.
  • Induction of interferon synthesis and activation of interferon-stimulated genes by liposom al transfection reagents. L I, X. L., BOYANAPALLI, M., W FIHUA, X., KALVAKOLANU, D . V., and HASSEL, B. A., Journal of Interferon And Cytokine Research, 1998, 18 (11), 947–952.
  • Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes. EUF, I., KUMAR, R., D ONG, Z., KILLICN, J. J., and FIDLER, I. J., Journal of Immunotherapy, 1998, 21 (5), 340–351.
  • Induction of protective T cells against Listeria monocytogenes in mice by immunization with a listeriolysin 0-negative avirulent strain of bacteria and liposome-encapsulated listeriolysin 0. TANABE, Y., X ICI\IG, H., NOMURA, T., A RAKAWA, M., and MITSUYAMA, M., Infection And Immunity, 1999, 67 (2), 568–575.
  • Inflammatory cytokine production in whole blood modified by liposome-encapsulated hemoglobin. NIWA, K., IKEJ3UCHI K., FUJIHARA, M., ABE, H., WAKAMOTQ S., ITO T., YAMAGUCHI, M., and SEKIGUCHI, S., Artificial Cells, Blood Substitutes, And Immobilization Biotechnology, 1998, 26 (5-6), 559–570.
  • Influence of emulsification on the preparation and permeability of microcapsules. FANG, K., WANG, Y CAI, Y., SHAQ Y., and WANG, J., Qingdao Daxue Xuebao, Gongcheng Jishuban, 1998, 13 (4), 9–12.
  • Influence of preparation factors on sustained release of nifedipine from Eudragit RL/RS microspheres. FU, C., JIANG, X., HU, J., and ZHANG, W., Journal of Chinese Pharmaceutical Sciences, 1997, 6 (4), 203–210.
  • Inhibitory effect of liposome-encapsulated piroxicam on inflammation and gastric mucosal damage. SAMMOUR, O. A., AL ZUHAIR, H. H., and EL SAYED, M. I., Pharmaceutical Industry, 1998, 60 (12), 1084–1087.
  • Interactions of polymeric and liposom al gene delivery systems with extracellular glycosa-minoglycans: physicochemical and transfection studies. RUFONEN, M., YLA, HERTTUALA, S., and URTTI, A., Biochimica et Biophysica Acta, 1999, 1415 (2), 331–341.
  • Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking. TACHEBANA, R., H ARASHIMA, H., S HON() M., A ZUMANQ M., NIWA, M., F UTAKI, S., and K IWADA, H., Biochemistry and Biophysics Research Communications, 1998, 251 (2), 538–544. ISSN: 0006-291X.
  • Intrahimoral injection of rhenium-188 microspheres into an animal model of hepatoma. WANG, S. J., LIN, W. Y., CHEN, M. N., CHI, C. S., CHEN, J. T., HQ W. L., HSIEH, B. T., SHEN, L. H., T SAI, Z. T., TING, ING, G., MIRZADEH, S., and KNAPP, F. F. JR, Journal of Nuclear Medicine, 1998, 39 (10), 1752–1757.
  • Intravenous pretreatment with empty pH gradient liposomes alters the pharmacokinetics and toxicity of doxorubicin through in vivo active drug encapsulation. MAYER, L. D., REAMER, J., and BALLY, M. B., Journal of Pharmaceutical Science, 1999, 88 (1), 96–102.
  • Investigation of a pMDI system containing chitosan microspheres and P134a. WILLIAMS, R. O. III, BARRON, M. K., JOSE, A. M., and REIvIUNAN, L. C., International Journal of Pharmacy, 1998, 174 (1-2), 209–222.
  • Investigation of the shear stresses experienced during melting using novel microencapsu-lated dye sensors. CLARK, D. C., GFRAMITA, K., and BAKER, W. E., Annual Technical Confernerzce of the Society of Plastic Engineers, 50, 1998, 1, 87–91.
  • Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain. RFZA, M. S., and WHATELEY, T. L., Journal of Microencapsulation, 1998, 15 (6), 789–801.
  • Kinetic analysis of the interaction between liposomes and the complement system in rat serum: re-evaluation of size-dependency. Yamada, M., Harashima, H.KIWADA, H., Bio-logical And Pharmaceutical Bulletin, 1998, 21 (9), 964–968.
  • Kinetics and toxicity of liposom al and conventional amikacin in a patient with a multidrug-resistant tuberculosis. WHITEHEAD, T. C., LOVERING, A. M., CROPLEY, I. M., WADE, P., and DAVIDSCN, R. N., European Journal of Clinical Microbiological Infectious Diseases, 1998, 17 (11), 794–797. ISSN: 0934–9723.
  • Kinetics of methemoglobin structural changes in the complex with liposomes. GORBENKCi G. P., Ukr Biokhim Zh, 1998, 70 (3), 68–72.
  • Lack of a nitric-oxide response during the course of Leishmania infantum infection in the golden hamster (Mesocricetus aurahis), with or without treatment with liposomal amphotericin B. BCRIES, C., COFFIN, C., MATHIEU, D., BCRIES, P. N., SCHERMAN, E., RIVOLLET, D., and DENIAU, M., Annals of Tropical Medicine Parasitology, 1998, 92 (6), 685–692.
  • Large and monodispersed polymeric microspheres with high butadiene rubber content via membrane emulsification. HA, Y. K., LEE, H. J., and KIM J. H., Colloids Surfactant, A, 1998, 145 (1-3), 281–284.
  • Lasalocid A facilitated dopamine uphill transport and concentration into liposomes driven by pH gradient generated by bacteriorhodopsin under illumination. QUAN, Z., SUGAWARA, M., and UMFZAWA, Y., Biosensitive Bioelectronics, 1998, 13 (11), 1157–1164.
  • Liposom al am photericin B compared with am photericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. LEEN DERS, A. C. A. P., DAENEN, S., JANSEN, R. L. H., HOP, W. C. J., LOWENBERG, B., WIJERMANS, P. W., CORNELISSEN J., HERBRECHT, R., VAN DER LELIE, H., HCITISTEDEN, H. C., VERBRUGH, H. A., and DE MARIE, S., British Journal of Haematology, 1998, 103 (1), 205–212.
  • Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. WALSH, T. J., FINBERG, R. W., ARNDT, C., HIEMENZ, J., SCHWARTZ, C., BCDENSTEINFR, D., PAPPAS, P., SEIBEL, N., GREENBERG, R. N., DUMMER, S., SCHUSTER, M., and HOLCENBERG, J. S., New England Journal of Medicine, 1999, 340 (10), 764–771.
  • Liposom al busulphan:bioavailability and effect on bone marrow in mice. HASSAN, Z., NILSSON, C., and HASSAN, M., Bone Marrow Transplantation, 1998, 22 (9), 913–918.
  • Liposom al daunorubicin: in vitro and in vivo efficacy in multiple m yelom a. PRATT, G., WILES, M. E., RAWSTRON, A. C., DAVIES, F. E., FENTON, J. A., PROFFHT, J. A., CHILD, J. A., SMITH, G. M., and MORGAN, G. J., Hematological Oncology, 1998, 16 (2), 47–55.
  • Liposom al drug formulations: rationale for development and what we can expect for the future. ALLEN T. M., Drugs, 1998, 56 (5), 747–756.
  • Liposome drug delivery system for murine neuroblastoma. NAGAF, I., KOYANAGI, Y., ITQ .S, TANABE, Y and UNFZAKI, S., Journal of Pediatric Surgery, 1998, 33 (10), 1521–1525.
  • Liposome entrapped allergen reduces plasma histamine in sensitized mice. ARCRA, N., and GANGAL, S. V., Asian Pacific Journal of Allergy And Immunology, 1998, 16 (2-3), 87–91.
  • Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes. PUKASAWA, M., SHIMEZU, Y., SHIKATA, K., NAKATA, M., SAKAKIBARA, R., YAMAMOTO N., HATANAKA, M., and MIZUOCHI, T., FEBS Letters, 1998, 441 (3), 353–356.
  • Liposome-bound Zn (H)-phthalocyanine. Mechanisms for cellular uptake and photosensiti-zation. RODAL, G. H., RODAL, S. K., MONN, J., and BERG, K., Journal of Photochemistry and Photobiology. B, Biology, 1998, 45 (2-3), 150–159.
  • Liposome-encapsulated Clodronate retards the development of experimental autoim mune uveitis. NIESMAN, M. R., NI, M., and BLOCK J. N., Journal of Liposome Research, 1998, 8 (3), 367–379.
  • Liposome-encapsulated m uram yl tripeptide phosphatidylethanolam ine adjuvant im m u-notherapy for splenic hem angiosarcom a in the dog: a randomized multi-institutional clinical trial. VAIL, D. M., MACEWEN, E. G., KURZMAN, I. D., DUBIFT ZIG, R. R., HELFAND, S. C., KISSEBERTH, W. C., LONDON, C. A., OBRADOVICH, J. E., MADEWELL, B. R., RODRIGUEZ C. O. JR., et al., Clinical Cancer Research, 1995, 1 (10), 1165–1170.
  • Liposome-mediated delivery of retinoids. MEHTA, K., ESTEY, E., and LOPEZ B. G., NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 87–94. ISSN: 0258–1213.
  • Liposome-mediated gene transfer in rat lung transplantation: A comparison between the in vivo and ex vivo approaches. BONSQUEVISQUE, C. H., MCRA, B. N., BOGLIONE M., RITTER, J. K., S CHEULE R. K., YEW, N., DEBRUYNF, L., QIN, L., BROMBERG, J. S., and PATTERSGN, G. A., Journal of Thoracic And Cardiovascular Surgery, 1999, 117 (1), 8–14; discussion 14–15.
  • Liposomes and artificial chaperones-design of stress responsive functional materials. KUBO R., Seisan to Gijutsu, 1998, 50 (4), 9–15.
  • Liposomes coated with chemically modified dextran interact with human endothelial cells. CANSELL M., PARISEL C., JCVETCNVICZ, J., and LETOURNEUR, D., Journal of Biomedical Materials Research, 1999, 44 (2), 140–148.
  • Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. COLIN, M., HARBOTTLE R. P., KNIGHT, A., KCRNPROBST, M., COOPER, R. G., M ILLER, A. D., TRUGNAN G., CAPFAU, J., CCUrFT T E C., and BRAHEME, H. M. C., Gene Therapy, 1998, 5(11), 1488–1498.
  • Liposomes for scintigraphic imaging: optimization of in vivo behavior. BCERMAN, O. C., OYIN, W. J., CORSTENS, F. H., and STCRM G., Quarterly Journal of Nuclear Medicine, 1998, 42(4), 271–219. 70 Refs.
  • Liposomes promote pulmonary glucocorticoid delivery. SUNTRES, Z. E., and S HEX, P. N., Journal of Drug Targeting, 1998, 6 (3), 175–182.
  • Loading of doxorubicin into liposomes by forming Mn2+ -drug complexes. CHEGNG, B. C. L., SUN, T. H. T., LFENHOUTS, J. M., and CULLIS, P. R., Biochimica et Biophysica Acta, 1998, 1414 (1-2), 205–216.
  • Long circulating liposomes: evolution of the concept. GREGCRIADIS, G., NAT 0 AS I Series, Series A, 1998, 300 (Targeting of Drugs 6), 35–40.
  • Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes. VERSLUIS, A. J., RENSEN, P. C., RUMP, E. T., VAN BERKEL, T. J., and BUSTE1BC604, M. K., British Journal of Cancer, 1998, 78 (12), 1607–1614.
  • Luciferin incorporation in the structure of acrylic microspheres with subsequent confine-ment in a polymeric film: a new method to develop a controlled release-based biosensor for ATP, ADP and AMP. MICHEL, P. E., GAUTIER, S. S. M., and BLUM, L. J., 1998, Talanta, 47 (1), 169–181.
  • Lysosome-disrupting peptide increases the efficiency of in-vivo gene transfer by liposome-encapsulated DNA. BARU, M., NAHUM O., JAARQ H., SHAANANI, J., and NUR, I., Journal of Drug Targeting, 1998, 6 (3), 191–199.
  • Membrane fusion and rupture in liposomes: effect of biodegradable pH-sensitive surfactants. LIANG, E., and HUGHES, J. A., Journal of Membrane Biology, 1998, 166 (1), 37–49.
  • Microcapsule agglutination test for the diagnosis of leptospirosis in Thailand. supur-TAMONGKCL, Y., SARAwisH, S., SILPASAKCRN, S., POTHA, U., SILPAPOTAKUL K., and NAIGOWIT, P., Annals Of Tropical Medicine And Parasitology, 1998, 92 (7), 797–801.
  • Microcapsule-containing nickel composite electroplates. SZEPTYCKA, B., Inz Powierzchni, 1998, (3), 31–45.
  • Microcapsules of alginate-chitosan-I A quantitative study of the interaction between alginate and chitosan. GASEROD, O., SMIDSROD, O., and SKJAK, B. G., Biomaterials, 1998, 19 (20), 1815–1825.
  • Microencapsulation in yeast cells. BISHOP, J. R., NELSCN, G., and LAMB, J., Journal of Micro-encapsulation, 1998, 15 (6), 761–773.
  • Microencapsulation of ginger oleoresin. XIANG, Y., LI, P., LIU, Q., JING, P., and LING, Z., T ianran Chanwu Y anjiu Yu Kaifa, 1997, 9 (4), 72–78.
  • Microencapsulation of hepatitis B core antigen for vaccine preparation. UCHIDA, T SHICSAKI, K., NAKADA, Y., FUKADA, K., EDA, Y., T0KIYcEHI, S NAGAREYA, N., and MATSUYAMA, K., Pharmaceutical Research, 1998, 15 (11), 1708–1713.
  • Microencapsulation of pesticides by interfacial polymerization utilizing isocyanate or aminoplast chemistry. SCHER, H. B., RODSON, M., and LEF, K. S., Pesticide Sciences, 1998, 54 (4), 394–400.
  • Microencapsulation of potassium iodide by simple coacervation method. SAIEULLAH, T. N., and FUDHOLI, A., Maj Farm Indonesia, 1998, 9(3), 116–122.
  • Microencapsulation processes and applications in textile processing. AGGARWAL, A. K., DAYAL, A., and KUMAR, N., Colourage, 1998, 45 (8), 15–18. 20–24.
  • Microencapsulation techniques. MANEKAR, N. C., and JCSIII, S. B., East Pharmaceutics, 1998, 41 (488), 47–49.
  • Microencapsulation: techniques and applications. SCUSA, J. P., and FERREIRA, J. P. M., Reviews in Port Farm, 1998, 48 (3), 97–104.
  • Microsphere based detoxification system. A new blood purification method: technical safety aspects. VOGT, G., SCHMIDT, C., SCHRE, A., STRa3L, W., MITTEREGER, R., WILLINGER, M., LOSFRT, U., SCHIMA, H., and FALKENHAGEN, D., Biomedizinische T echnik, 1998, 43 (Suppl), 170–171.
  • Microsphere embolism-induced changes in noradrenaline uptake of the cerebral cortex in rats. HAYASHI, H., HIROTA, S., and T AKECt S., Brain Research, 1998, 808 (2), 190-196. Modulation of annexin VI-driven aggregation of phosphatidylserine liposomes by ATP. BANDOROWIC4 P. J., and PIKULA, S., Biochimie, 1998, 80 (7), 613–620.
  • Morphological transformation of liposomes caused by assembly of encapsulated tubulin and determination of shape by microtubule-associated proteins (MAPs). KANEKO T., ITOH, T. J., and HarAm, H., Journal of Molecular Biology, 1998, 284 (5), 1671–1681.
  • Morphology dependent resonant lasing of a dye-doped microsphere prepared by non-linear optical material. T AKAHASHI, T., M ATSUO S., M ISAWA, H., KARATSU, T., KITAMURA, A., KAMADA, K., and offrA, K., Thin Solid Films, 1998, 331 (1, 2), 298–302.
  • Nebulizers for the generation of liposomal aerosols. BRIDGES, P. A., and TAYLOR, K. M. G., International Journal of Pharmaceutics, 1998, 173 (1, 2), 117–125.
  • New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres. BLANCO P. M. J., FATTAL, E., PUISIEUX, F., and COUVREUR, P., Annales Pharmaceutiques Francaises, 1998, 56 (6), 256–263.
  • NGF release from poly(D, t-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. PEAN, J. M., VENTER, J. M. C., BOURY, F., MENFI, P., DENIZOT, B., and BENOIT, J. P., Journal of Controlled Release, 1998, 56 (1-3), 175–187.
  • Nifedipine loaded-polymeric microspheres: preparation and physical characteristics. GUYOT, M., and FAWAZ F., International Journal of Pharmacy, 1998, 175 (1), 61–74.
  • Nonclinical safety assessment of intravenous OPTISON: a perfluoropropane (PFP)-filled albumin microspheres contrast agent for ultrasonography. GREENER, Y., KILLAM, A. L., CORNELL, S. T., OSHERCFF, M. R., and WCLFORD, S. T International Journal of Toxicology, 1998, 17 (6), 631–662.
  • Novel flow cytometry compensation standards: internally stained fluorescent microspheres with matched emission spectra and long-term stability. ZHANG, Y. Z., KEMPER, C., BAKKF, A., and HAUGLAND, R. P., Cytometry, 1998, 33 (2), 244–248.
  • Nucleic acid transfection technique and cation liposome. WANG, D., and LIN, Q., Xibao Shengwuxue Zazhi, 1998, 20 (1), 21–25.
  • Opposite beta-2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity. CFT T I, C. M., GHARAVI, A. E., and CHAIMOVICH, H., Biochimica et Biophysica Acta, 1999, 1416 (1-2), 225–238.
  • Paramagnetic liposomes as magnetic resonance imaging contrast agents: Assessment of contrast efficacy in various liver models. FC8SHFIM S. L., CCLET, J. M., MANSSCN, S., FAHLVIK, A. K., MULLER, R. N., and KLAVENFSS, J., Investigating Radiology, 1998, 33(11), 810–821.
  • Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. FOSSHFIM S. L., FAHLVIK, A. K., KLAVENFSS, J., and MULLER, R. N., Magnetic Resonance Imaging, 1999, 17 (1), 83–89.
  • Particle size control in the preparation of hollow silica microspheres by an emulsion/ extraction method. LEE, K. H., and KIM H., Hwahak Konghak, 1998, 36 (5), 701–706.
  • Periarticular bone alterations in chronic antigen-induced arthritis: free and liposome-encapsulated clodronate prevent loss of bone mass in the secondary spongiosa. OELZNER, P., BRAUER, R., H EN/GEN S., T HOSS, K., W UNSCHE B., H ERSMANN, G., A BENDROTH, K., and KINNE, R. W., Clinical Immunology, 1999, 90 (1), 79–88.
  • pH-sensitive release of indomethacin using lactan-acetate microspheres. NA, K., and LEFT. K. Y., Drug Development and Industrial Pharmacy, 1998, 24 (6), 563–568.
  • Pharmacodynamic and pharmacokinetic evaluation of lipid microspheres of indomethacin. SRINATH P., and DIWAN, P. V., Pharmaceutica Acta Helvetica, 1998, 73 (4), 199–203.
  • Pharmacokinetics and tissue distribution of carboplatin albumin microspheres after em bol-ization in hepatic artery. ZHU, H., JIANG, X., CHEN, G., and XU, F., Zhongguo Y iyuan Y aoxue Zazhi, 1998, 18 (4), 147–148.
  • Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. PEREZ S. R., SHIN, D. M., S IDDIK, Z. H., MURPHY, W. K., HUBER, M., LEE, EF, S. J., K IRXHAR, A. R and H CNG, W. K., Clinical Cancer Research, 1997, 3 (3), 373–379.
  • Phase II trial of liposom al daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. TULPULE, A., YUNG, R. C., W ERNZ, J., ESPINA, B. M., M YFRS, A., S CADDEN, D. T., CABRIALFS, S., ILAW, M., BOSWELL, W., and GILL, P. S., Journal of Clinical Oncology, 1998, 16 (10), 3369–3374.
  • Photochromism of spirooxazines in homogeneous solution and phospholipid liposomes. KHAIRUTDINCN, R. F., GIERTZ K., HURST, J. K., VOLC6HINA, E. N., VOLOSHIN, N. A., and MINKIN, V. I., Journal of the American Chemical Society, 1998, 120 (49), 12707–12713.
  • Photoinduced destabilization of sterically stabilized liposomes. BCNDURANT, B., and OBRIEN, D. F., Journal of the American Chemical Society, 1998, 120 (51), 13541–13542.
  • Physical properties and pharmacological activity in vitro and in vivo of optimized liposomes prepared from a new cancerostatic alkylphospholipid. ZEISIG, R., ARNDT, D., STAHN, R., and FICHTNER, I., Biochimica et Biophysica Acta, 1998, 1414 (1-2), 238–248.
  • Physico-chemical characterization of liposomes with covalently attached hepatitis A VP3(101-121) synthetic peptide. MUNOZ M., ALSINA M. A., GARCIA, M., REIG, F., and HARO I., Analyst (Cambridge, UK), 1998, 123 (11), 2223–2228.
  • Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L4actide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene) Influence of production method and polymer composition. LUCK, M., PISTFL, K. F., LI, Y. X., BLUNIC, T., MULLER, R. H., and KISSEL, T., Journal of Controlled Release, 1998, 55(2, 3), 107–120.
  • PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryo-preparation and carbohydrate stabilization. ANDO S., PUTNAM D., PACK, D. W., and LANGER, R., Journal of Pharmaceutical Science, 1999, 88 (1), 126–130.
  • PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. LEMPERLE, G., GAUTHIER, H. N., and LEMPERLF, M., Aesthetic Plastic Surgery, 1998, 22 (5), 356–365.
  • Poly(DL-lactic acid) microspheres for controlled drug delivery systems. RAMESH, D. V., TABATA, Y., and IKADA, Y., Indian Journal of Pharmaceutical Science, 1998, 60 (4), 232–234.
  • Poly(ethylene glycol) derivative of cholesterol reduces binding step of liposome uptake by m urine macrophage-like cell line 3774 and hum an hepatom a cell line HepG2. ISHIWATA, H., SATO S. B., KOBAYASHI, S., OKU, M., VFRTUT, D. A., and MIYAJIMA, K., Chemical and Pharmaceutical Bulletin (Tokyo), 1998, 46 (12), 1907–1913.
  • Poly(L-lactic acid) microspheres for pulmonary drug delivery: release kinetics and aero-solization studies. EL BASEIR, M. M., and KFLLAWAY, I. W., International Journal of Pharmaceutics, 1998, 175 (2), 135–146.
  • Polyethylene glycol derivative of cholesterol reduces binding step of liposome uptake by m urine macrophage-like cell line 3774 and hum an hepatom a cell line HepG2.ISHIWATA, H., S ATO S. B., KOBAYASHI, S OKU, M VFRTUT, D. A., and MIYAJIMA, K., Chemical Pharmaceutical Bulletin, 1998, 46 (12), 1907–1913.
  • Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. PHILLIPS, W. T., KLIPPER, R. W., AWASTHI, V. D., RUDOLPH, A. S., CLIFF, R., KWASIBORSKL V., and GOINS, B. A., Journal of Pharmacology and Experimental Therapeutics, 1999, 288 (2), 665–670.
  • Polysialic acids: potential for long circulating drug, protein, liposome and other m icropar-ticle constructs. GREGCRIADIS, G., FERNANDES, A., MCCCRMACK, B., MITAL, M., and ZHANG, X., NATO AS I Series, Series A, 1998, 300 (Targeting of Drugs 6), 193–205.
  • Porosity of whey protein-based microcapsules containing anhydrous milkfat measured by gas displacement pycnometry. MCREAU, D. L., and ROSENBERG, M., Journal of Food Science, 1998, 63 (5), 819–823.
  • Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity. Z CU, Y., PRIEBE, W S TEPHENS, L. C., and PEREZ S. R., Clinical Cancer Research, 1995, 1(11), 1369–1374.
  • Preparation and characterization of alginate microspheres containing a model antigen. LEMOINF, D., WAUTERS, F., BCUCHENDHOMMF, S., and PREAT, V., International Journal of Pharmaceutics, 1998, 176 (1), 9–19.
  • Preparation and characterization of echogenic liposome as an ultrasound contrast agent: size-dependency and stabilizing effect of cholesterol on the echogenicity of gas-entrapping liposome. KIMURA, A., SAKAI, A., T SUKISHERQ S. I., BEPPU, S., and FUJIWARA, H., Chemical Pharmaceutical Bulletin, 1998, 46 (10), 1493–1496.
  • Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. LEFT. B. J., CHCE J. S., and KIM C. K., Journal of Microencapsulation, 1998, 15 (6), 775–787.
  • Preparation and characterization of oil-in-water type poly (m-lactic acid) microspheres containing testosterone enanthate. TSUBUKU, S., SUGAWARA, S., MIYAJIMA, M., YOSHIDA, M., AsANo M., OKABE, K., KGBAYASHI, D., and YAMANAKA, H., Drug Development and Industrial Pharmacy, 1998, 24 (10), 927–934.
  • Preparation and in vitro release studies of ibuprofen-loaded films and microspheres made from graft copolymers of poly(i-lactic acid) on acrylic backbones. GALLARDQ A., EGUIBURU, J. L., JCSE, F. B. M., and SAN ROMAN, J., Journal of Controlled Release, 1998, 55 (2, 3), 171–179.
  • Preparation and properties of perfume microcapsules. ZOU, L., WANG, Y., and WANG, Y., Zhongguo Fangzhi Daxue Xuebao, 1998, 24 (1), 1–4.
  • Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy. CCNZONE, S. D., HAIFELI, U. 0., DAY, D. E., and EHRHARDT. G. J., Journal of Biomedical Materials Research, 1998, 42 (4), 617–625.
  • Preparation and release behavior of ethyl cellulose microcapsule by using polystyrene and polystyrene copolymer containing hydroxyl as the co-wall materials. CHEN, H., TSAI, Y. L., and LIU, T. C., Huaxue, 1998, 56 (3), 147–155.
  • Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats. DSOUZA, M., and DESOUZA, P., Drug Development and Industrial Pharmacy, 1998, 24 (9), 841–852.
  • Preparation of bovine serum albumin microspheres by an acetone-ethanol heat denaturation method. HE, L., CHEN, G., LU, Y., and CHEN, J., Journal of Chinese Pharmaceutical Science, 1997, 6 (2), 82–89.
  • Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. BAYOM, M. A., AL SUWAYEH, S. A., EL HELW, A. M., and MESNAD, A. F., Pharmaceutica Acta Helvetica, 1998, 73 (4), 187–192.
  • Preparation of ethyl cellulose microcapsules containing perphenazine and polymeric per-phenazine based on acryloyl chloride for physical and chemical studies of drug release control. ZANDI, M., POURTAVADI, A., HASHEME, S. A., and ARABI, H., Polymer Inter-national, 1998, 47 (4), 413–418.
  • Preparation of hydrophobic microspheres from low-temperature melting polymeric materials. NALASKOWSKI, J., DRELICH, J., HUPKA, J., and MILLER, J. D., Journal of Adhesive Science Technology, 1999, 13 (1), 1–17.
  • Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy. KING K., ICHIKAWA, H., FUJIOKA, K., FUKUMCRI, Y., AKINE, Y., and T OKUUYE, K., Chemical and Pharmaceutical Bulletin (Tokyo), 1999, 47 (1), 54–63.
  • Preparation of poly(m ethyl methacrylate) microcapsules with liquid cores. LOXLEY, A., and VINCENT, B., Journal of Colloid Interface Science, 1998, 208 (1), 49–62.
  • Preparation of sustained release microcapsules of glipizide and its dissolution pattern. CHEN, Y., and YANG, S., Guangdong Yaoxueyuan Xuebao, 1998, 14 (2), 86–88.
  • Preparation of 153Sm-resin microspheres and determination of femoral bone blood flow in rabbits. BAT, H., CHENG, Z., JIN, X., DU, J., WANG, F., CHEN, D., FAN, H., ZHANG, N., YANG, L., and LI, Z., T ongweisu, 1998, 11 (1), 39–43.
  • Procion Red MX-3B-derived poly(HEMA/EGDMA) microspheres for removal of cadmium ions. DENIzu, A., BUYUKTUNCEL, E., GFNC, O., and PISKIN, E., Analytical Letters, 1998, 31 (15), 2791–2804.
  • Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres. DRAGER, C., BENZIGER, D., GAQ F., and HEADE, C. B., Anesthesiology, 1998, 89 (4), 969–979.
  • Prolonged local anesthetic effect of bupivacaine liposomes in rats. YU, H. Y., SUN, P., and HOU, W. Y., International Journal of Pharmaceutics, 1998, 176 (1), 133–136.
  • Prolonged systemic delivery of streptokinase using liposome. KIM I. S., CHOI, H. G., CHOI, H. S., KIM B. K., and KIM, C. K., Archives of Pharmacal Research, 1998, 21 (3), 248-252. Properties of porous starch and its application in microencapsulation for food. HASEGAWA, N., Shokuhin Kogyo, 1998, 41 (18), 42–50.
  • Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. CROTES, G., and PARK, T. G., Journal of Microencapsulation, 1998, 15 (6), 699–713.
  • Protein-mediated DNA transfer into liposomes. LAMBERT, O., PLANCON, L., RIGAUD, J. L., and LETELLIER, L., Molecular Microbiology, 1998, 30 (4), 761–765.
  • Pulmonary gas-exchange analysis by using simultaneous deposition of aerosolized and injected microspheres. ALTEMEER, W. A., ROBERTSON, H. T., and GLENNY, R. W., Journal of Applied Physiology, 1998, 85 (6), 2344–2351.
  • Quantitative immunohistochemistry of androgen receptors in a microsphere model system and in prostate tissue sections. HCUTSMULLER, A. B., JANSSEN, P. J., NIGG, A. L., HOEDEMAEKER, R. F., and VAN DER KWAST, T. H., Analytical and Quantitative Cytology and Histology, 1998, 20 (5), 365–372.
  • Raman spectroscopic characteristics of microcosmic and photosensitive damage on space structure of liposomes sensitized by hypocrellin and its derivatives. XU, Y., ZHANG, Z., and ZHANG, W., Science in China, Series C: Life Sciences, 1998, 41 (5), 459–464.
  • Reconstructed human skin as model for liposome-skin interaction. ZELLMER, S., REISSIG, D., and LASCH, J., Journal of Controlled Release, 1998, 55 (2, 3), 271–279.
  • Release of tetanus toxoid from adjuvants and PLGA microspheres: How experimental set-up and surface adsorption fool the pattern. JOHANSEN, P., CCRRADIN, G., MERKLF, H. P., and GANDER, B., Journal of Controlled Release, 1998, 56 (1-3), 209–217.
  • Reversal of hyperglycemia in streptozotocin diabetic mice by xenotransplantation of micro-encapsulated rat islets. T ATARKIEWICZ K., SITAREK, E., SABAT, M., and ORLOWSICE, T., Annals of Transplantation, 1997, 2 (2), 20–23.
  • Rhenium-188 microspheres: a new radiation synovectomy agent. WANG, S. J., UN, W. Y., CHEN, M. N., HSIEH, B. T., SHEN, L. H., TSAI, Z. T., TING, G., CHEN, J. T., HQ W. L., MIRZADEH, S., and KNAPP, F. F. JR, Nuclear Medicine Communications, 1998, 19 (5), 427–433.
  • Rhinocerebral mucorm ycosis following donor leukocyte infusion: successful treatment with liposom al am photericin Band surgical debridement. PFNALVER, F. J., ROMERQ R., FORFS, R., CABRERA, R., DIE4 M. J. L., REGIDCR, C., and FERNANDEZ M. N., Bone Marrow Trans-plantation, 1998, 22 (8), 817–818.
  • Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors. BOIARDI, A., PCYZT, A., SALMAGGI, A., EOLI, M., ZUOCHETTI, M., and SILVANI, A., Cancer Chemotherapy and Pharmacology, 1999, 43 (2), 178–179.
  • Safety study and characterization of E1A-liposome complex gene-delivery protocol in an ovarian cancer model. XING, X., ZHANG, S., CHANG, J. Y., TUCKER, S. D., CHEN, H., HUANG, L., and HUNG, M. C., Gene Therapy, 1998, 5 (11), 1538–1544.
  • Solubilization of model stratum corneum liposomes by quaternary ammonium surfactants. DE LA MAZA, A., CCDERCH, L., LOPEZ, O., GONZALEZ P., BAUCELLS, J., and PARRA, J. L., Journal of Surfactants Detergents, 1998, 1 (4), 491–497.
  • Soybean protein hydrolyzate as microencapsulating agents for 8-carotene. ZHU, X., XU, S., and WANG, Z., Shipin Yu Fajiao Gongye, 1998, 24 (3), 13–15. 19.
  • Specific inhibition of influenza virus RNA polym erase and nucleoprotein gene expression by liposom ally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells. ABE, T., SUZUICI, S., HATTA, T., T AKAL K., YOKOTA, T., and TAKAKU, H., Antiviral Chemistry and Chemotherapy, 1998, 9 (3), 253–262.
  • Stealth liposomes as carriers of doxorubicin. GCREN, D., ZALIPSICY, S., HCROWIT4 A. T., and GABIZON, A., NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 77–85.
  • Stealth liposomes for the targeting of drugs in cancer therapy. ALLEN, T. M., DEMENEZES, D. L., HANSEN, C. B., and MOASF, E. H., NATO AS I Series, Series A, 1998, 300 (Targeting of Drugs 6), 61–75.
  • Structure, morphology and degradation of poly(a-hydroxy acid)s microspheres in relation with monolayers. PROUST, J. E., BOURY, F., SAULNIER, P., BENOIT, J. P., PANAIOTOV, I., and IVANOVA, T., Current Top Colloid Interface Science, 1997, 1, 195–224.
  • Studies on preparation technology for oral microspheres of hepatocyte growth-promoting factor. ZHANG, H., CHEN, Y., CHEN, W., YU, Z., and ZHANG, Y Zhongguo Shenghua Yaowu Zazhi, 1998, 19 (4), 180–183.
  • Studies on small (350 um) alginate-poly-L-lysine microcapsules. Ill. Biocompatibility of smaller versus standard microcapsules. ROBITAILLE, R PARISEAU, J. F., LEBLOND, F. A., LAMOUREUX, M., LEPAGE, Y., and HALLE, J. P., Journal of Biomedical Materials Research, 1999, 44 (1), 116–120.
  • Study of liposom es entrapped mite allergen. ZBENG, Y LIANG, C., HE, Y., YIN, R., and LONG, R., Mianyixue Zazhi, 1998, 14 (3), 191–193.
  • Study of liposomes of mimetic red cells. HOU, X., QIU, Y., and ZHANG, J., Journal of Chinese Pharmaceutical Science, 1997, 6 (4), 198–202.
  • Study on drug controlled release of magnetic cisplatin microspheres. WANG, P., WANG, G., MA, J., LI, P., and MO Y Zhongguo Y aoxue Zazhi (Beijing), 1998, 33 (9), 537–540.
  • Study on sucrose-menthol cocrystallized microcapsule. LI, G., Shipin Gongye Keji, 1998, (5), 14–15.
  • Study on the microencapsulation of reversible therm ochromic composite materials using epoxy resin E-12. SONG, J., LI, G., and CHENG, L., Jingxi Huagong, 1998, 15 (5), 27–30.
  • Successful treatment of an invasive aspergillosis of the skull base and paranasal sinuses with liposomal am photericin B and itraconazole. STREPPEL, M., BACHMANN G., ARNOLD, G., DAMM, M., and STENNERT, E., Annals of Otology, Rhinology and Laryngology, 1999, 108 (2), 205–207.
  • Sugar cross-linked gelatin for controlled release: microspheres and disks. CCRTESI, R., NASTRUZE, C., and DAVIS, S. S., Biomaterials, 1998, 19 (18), 1641–1649.
  • Superparamagnetic nanoparticles containing liposom es as potential specific contrast agent for brain MR imaging: initial feasibility study by a combined approach with 59Fe-activated track-autoradiography. WITTENDCRP, R. E., NAMER, I. J., STEEBEL, J., LAM, D. C., and POULIQUIN, D., Journal of Trace Microprobe Technology, 1998, 16 (4), 523–534.
  • Surface and morphology of spray-dried pegylated PLA microspheres. LACASSF, F. X., HILDGFN, P., and MCMULLEN J. N., International Journal of Pharmaceutics, 1998, 174 (1-2), 101–109.
  • Surface-modified biodegradable albumin nano- and microspheres. Part 2. Effect of surface charges on in vitro phagocytosis and biodistribution in rats. RCSER, M., FISCHER, D., and KISSEL, T., European Journal of Pharmaceutics and Biopharmaceutics, 1998, 46 (3), 255–263.
  • Synthesis and properties of pressure-sensitive color—developing microcapsule—effects of the dosage of system modifier and the pH of microcapsule slurry on the properties of microcapsule. LU, J., PAN, J., CHEN, S., and HUA, Z., Zhongguo Fangzhi Daxue Xuebao, 1998, 24 (1), 5–8.
  • Synthesis of monodisperse polystyrene m icrosphere. GU, Y., LI, C., LIU, C., and XU, X., Shandong Jiancai Xueyuan Xuebao, 1998, 12 (3), 220–222.
  • Target-cell specificity of fusogenic liposomes: membrane fusion-mediated macromolecule delivery into hum an blood mononuclear cells. WATABE, A., YAMAGUCHI, T., KAWANISBI, T., UCHIDA, E., EGUCHI, A., MIZUGUCHI, H., MAYUML T., NAKANISIII, M., and HAYAKAWA, T., Biochimica et Biophysica Acta, 1999, 1416 (1-2), 339–348.
  • Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG. DAMS, E. T., °YEN, W. J., BOERMAN, O. C., STORM, G., LAVERMAN, P., KOENDERS, E. B., VAN DER MEER, J. W., and CORSTENS, F. H., Journal of Nuclear Medicine, 1998, 39 (12), 2172–2178.
  • The application of microspheres from the copolymers of lactide and a-caprolactone to the controlled release of steroids. BUNTNER, B., NOWAK, M., KASPERCZYK, J., RYBA, M., GRIEB, P., WALsm, M., DOBRZYNSKI, P., and BERCI M., Journal of Controlled Release, 1998, 56 (1-3), 159–167.
  • The capacity of a combined liposom al hepatitis B and C vaccine to stimulate hum oral and cellular responses in mice. KBEMKA, V., SEE, D., SEE, J., CHANG, J., CHOU, S., and TILLFS, J., Viral Immunology, 1998, 11 (2), 73–78.
  • The dependence of membrane permeability by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposom es of different composition. WANG, W., SMITH, D. K., MOULDING, K., and CHEN, H. M., Journal of Biological Chemistry, 1998, 273 (42), 27438–27448.
  • The effect of core-to-wall ratio and Span 80 concentration on the properties of ascorbic acid microcapsules. VANICHTANUNKuL, D., VAYumHASUWAN, P., and NIMMANNIT, U., Journal of Microencapsulation, 1998, 15 (6), 753–759.
  • The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro. STERN, M., SORGI, F., HUGHES, C., CAPLFN, N. J., BROWNING, J. E., MIDDLETON, P. G., GRUENERT, D. C., FARR, S. J., HUANG, L., GEDDES, D. M., and ALTON, E. W., Gene Therapy, 1998, 5(5), 583–593.
  • The formation of ceramide-l-phosphate during neutrophil phagocytosis and its role in liposome fusion. HINKOVSKA, G. V. T., BOXER, L. A., MANSFIELD, P. J., HARSH, D., BLACK-WOOD, A., and SHAYMAN, J. A., Journal of Biological Chemistry, 1998, 273 (50), 33203–33209.
  • The influence of polymers on the physical stability and the thermal properties of dim yristoyl-phosphatidylcholine liposomes. GROHMANN, F. L., CSEMPESZ, F., and SZOGYI, M., Pharmaz ie, 1999, 54 (1), 52–55.
  • The mechanism of detergent solubilization of liposom es and protein-containing membranes. KRAGH, H. U., LE MAIRF, M., and MOLLER, J. V., Biophysics Journal, 1998, 75 (6), 2932–2946.
  • The nucleation and growth of calcium phosphate crystals at protein and phosphatidylserine liposome surfaces. NANCOLLAS, G. H., T SCRTOS, A., and ZIEBA, A., Scanning Microscopy, 1996, 10 (2), 499–508.
  • The potential of liposomes in oral drug delivery. ROGERS, J. A., and ANDERSON, K. E., Critical Reviews in Thermal Drug Carrier Systems, 1998, 15 (5), 421–480.
  • The preparation of liposome by using hexadecylphosphocholine (HPC) and its cytotoxic activity assay on HL-60 cells. Wu, L. J., WANG, Y. Z., and NIE, S. Q., Zhongguo S hengwu Huaxue Yu Fenzi S hengwu X uebao, 1998, 14 (5), 617–621.
  • The resin/hardener ratio as a processing parameter for modifying the mechanical behavior of epoxy-m atrix/glass microsphere composites. D'ALMEIDA, J. R. M., and MCNTERG S. N., Compositonal Science Technology, 1998, 58 (10), 1593–1598.
  • Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encap-sulated in long-circulating pegylated stealth liposomes. VAAGF, J., DCNOVAN, D., WIPFF, E., ABRA, R., COLBERN, G., USTFR, P., and WCRKING, P., International Journal of Cancer, 1999, 80 (1), 134–137.
  • Thermosensitive polymer-modified liposomes that release contents around physiological tem pe ratu re . KONQ K., NAKM, R., MCRIMOID K., and T AKAGISHI T., Biochimica et Biophysica Acta, 1999, 1416 (1-2), 239–250.
  • Time-dependent changes in the ischemic forebrain following the microsphere-induced permanent occlusion of cerebral arterioles in rats. OKUYAMA, K., KIUCHI s., oxAmarct M., IWASAKI, H., NARITA, H., and KUDO Y., Japanese Journal of Pharmacology, 1998, 78 (1), 31–37.
  • Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis. WilitTow, S. M., PLEYFR, U., LAI, J. C., LUIZ S., Mow:mum, M., and CHAN, C. C., Ocular Immunology and Inflammation, 1998, 6 (1), 51–56.
  • Toward artificial cells. Cell-shaped liposomes encapsulating cytoskeletons. HOTANI, H., Jikken Igaku, 1999, 17 (1), 24–29.
  • Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein. RAQ M., ROTHWELL, S. W., WASSEF, N. M., KOOLWAL, A. B., and ALVING, C. R., Experimental Cell Research, 1999, 246 (1), 203–211.
  • Transfection of cultured myoblasts in high serum concentration with DODAC:DOPE lipo-somes. VITIELLQ L., BOCKHOLD, K., JOSHI, P. B., and WCRTON, R. G., Gene Therapy, 1998, 5(10), 1306–1313.
  • Treatment with liposome-bound recombinant human tumor necrosis factor-alpha sup-presses parasitemia and protects against Plasmodium berghei k173-induced experi-mental cerebral malaria in mice. PCSTMA, N. S., CROMMELIN D. J., ELING, W. M., and ZUIDEMA, J., Journal of Pharmacology and Experimental Therapeutics, 1999, 288 (1), 114–120.
  • Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. YANG, T. H., DUNG, A., MEYER, J., JOHNSCN O. L., CLELAND, J. L., and CARPENTER, J. F., Journal of Pharmaceutical Science, 1999, 88 (2), 161–165.
  • Use of natural polysaccharides in the microencapsulation techniques. MURANQ E., Journal of Applied Ichthyology, 1998, 14 (3-4), 245–249.
  • Validation of a filtration vessel to determine regional blood flow of the heart using fluor-escent microspheres. RAAB, S., THEN, E., HARRIS, A. G., HABLFR, O., KLFEN, M., PAW, A., MESNER, F., and MESSMER, K., Biomediz inische T echnik, 1998, 43 (Suppl), 538–539.
  • Validation of a robot for determination of regional perfusion with fluorescent microspheres. THEN, E., RAAB, S., HARRIS, A. G., KLEIN, M., HABLFR, O., PAPE, A., MESSNER, F., and MEssmER, K., Biomedizinische T echnik, 1998, 43 (Suppl), 536–537.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.